Clonal Hematopoiesis and Heart Risk
Quick Facts
What Is Clonal Hematopoiesis and Why Does It Affect the Heart?
Clonal hematopoiesis of indeterminate potential, often shortened to CHIP, becomes more common with aging. It is usually found incidentally on genetic testing and does not mean a person has leukemia or another blood cancer. However, large cohort studies have linked CHIP to higher risks of coronary heart disease, stroke and overall mortality, partly because mutated immune cells may produce more inflammatory signals inside blood vessels.
The cardiovascular connection matters because atherosclerosis is not simply a cholesterol-storage disease. It is also an inflammatory process in which immune cells help drive plaque formation, plaque instability and clotting. CHIP-related mutations in genes such as TET2, DNMT3A and ASXL1 may change how white blood cells behave, making prevention strategies that reduce vascular inflammation especially relevant.
Can Sleep and Exercise Reduce the Cardiovascular Risk From Mutated Blood Cells?
The new Medical Xpress report describes research suggesting that sleep quality and regular exercise may blunt some of the heart risk associated with mutant white blood cells. That interpretation fits broader prevention science: physical activity improves blood pressure, insulin sensitivity, endothelial function and inflammatory balance, while poor sleep is linked to hypertension, obesity, diabetes and higher cardiovascular risk.
WHO guidelines recommend adults aim for at least 150 to 300 minutes of moderate-intensity aerobic physical activity each week, or 75 to 150 minutes of vigorous activity, plus muscle-strengthening work. The American Heart Association also includes sleep duration as part of cardiovascular health through Life's Essential 8, reflecting the growing recognition that sleep is a biological risk factor rather than a lifestyle afterthought.
Should People Be Tested for CHIP After This Research?
Most people with CHIP never develop a blood cancer, and there is no standard treatment that removes the mutated blood cell clone. For that reason, experts generally do not recommend population-wide screening outside specific clinical contexts. The more practical implication is that when CHIP is found, clinicians may look more closely at traditional cardiovascular risks such as blood pressure, LDL cholesterol, smoking, diabetes, kidney disease, sleep and physical inactivity.
Patients should not interpret CHIP as destiny. The emerging message is more actionable: age-related blood mutations may raise baseline risk, but the downstream cardiovascular consequences may still be modified through evidence-based prevention. That includes statins when indicated, blood pressure control, diabetes prevention or treatment, exercise, adequate sleep and smoking cessation.
Frequently Asked Questions
No. CHIP means a detectable clone of blood cells carries certain mutations, but there is no diagnosed blood cancer. The yearly risk of progression is usually low, although higher-risk mutation patterns need specialist interpretation.
No. Exercise is not known to remove CHIP mutations. Its potential benefit is reducing cardiovascular stress through better blood pressure, vascular function, insulin sensitivity and inflammation control.
For most adults, major cardiovascular health guidance generally treats 7 to 9 hours of sleep per night as a healthy range, though individual medical needs can vary.
References
- Medical Xpress. Sleep and exercise may curb heart risk from mutant white blood cells. June 2026.
- Jaiswal S, Natarajan P, Silver AJ, et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. The New England Journal of Medicine. 2017.
- Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015.
- World Health Organization. WHO Guidelines on physical activity and sedentary behaviour. 2020.
- Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health. Circulation. 2022.